EMEA (Europe, Middle East and Africa) Recombinant Antibody Market Report 2017

December 2017 | 104 pages | ID: EC74A4B3FAEEN
QYResearch

Abstracts

In this report, the EMEA Recombinant Antibody market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Pcs), revenue (Million USD), market share and growth rate of Recombinant Antibody for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Recombinant Antibody market competition by top manufacturers/players, with Recombinant Antibody sales volume (K Pcs), price (USD/Pcs), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Abnova
• Medix Biochemica
• GE Healthcare
• SinoBiological
• Bioventix

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

• Chimeric Antibody
• Humanized Antibody
• Full Human Antibody
• Single Chain Antibody
• Bispecific Antibody

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Hospital
• Scientific Research
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Recombinant Antibody Market Report 2017

1 RECOMBINANT ANTIBODY OVERVIEW

1.1 Product Overview and Scope of Recombinant Antibody
1.2 Classification of Recombinant Antibody
  1.2.1 EMEA Recombinant Antibody Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Recombinant Antibody Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Chimeric Antibody
  1.2.4 Humanized Antibody
  1.2.5 Full Human Antibody
  1.2.6 Single Chain Antibody
  1.2.7 Bispecific Antibody
1.3 EMEA Recombinant Antibody Market by Application/End Users
  1.3.1 EMEA Recombinant Antibody Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Hospital
  1.3.3 Scientific Research
  1.3.4 Others
1.4 EMEA Recombinant Antibody Market by Region
  1.4.1 EMEA Recombinant Antibody Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Recombinant Antibody (2012-2022)
  1.5.1 EMEA Recombinant Antibody Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Recombinant Antibody Revenue and Growth Rate (2012-2022)

2 EMEA RECOMBINANT ANTIBODY COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Recombinant Antibody Market Competition by Players/Manufacturers
  2.1.1 EMEA Recombinant Antibody Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Recombinant Antibody Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Recombinant Antibody Sale Price by Players (2012-2017)
2.2 EMEA Recombinant Antibody (Volume and Value) by Type/Product Category
  2.2.1 EMEA Recombinant Antibody Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Recombinant Antibody Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Recombinant Antibody Sale Price by Type (2012-2017)
2.3 EMEA Recombinant Antibody (Volume) by Application
2.4 EMEA Recombinant Antibody (Volume and Value) by Region
  2.4.1 EMEA Recombinant Antibody Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Recombinant Antibody Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Recombinant Antibody Sales Price by Region (2012-2017)

3 EUROPE RECOMBINANT ANTIBODY (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Recombinant Antibody Sales and Value (2012-2017)
  3.1.1 Europe Recombinant Antibody Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Recombinant Antibody Revenue and Growth Rate (2012-2017)
3.2 Europe Recombinant Antibody Sales and Market Share by Type
3.3 Europe Recombinant Antibody Sales and Market Share by Application
3.4 Europe Recombinant Antibody Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Recombinant Antibody Sales Volume by Countries (2012-2017)
  3.4.2 Europe Recombinant Antibody Revenue by Countries (2012-2017)
  3.4.3 Germany Recombinant Antibody Sales and Growth Rate (2012-2017)
  3.4.4 France Recombinant Antibody Sales and Growth Rate (2012-2017)
  3.4.5 UK Recombinant Antibody Sales and Growth Rate (2012-2017)
  3.4.6 Russia Recombinant Antibody Sales and Growth Rate (2012-2017)
  3.4.7 Italy Recombinant Antibody Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Recombinant Antibody Sales and Growth Rate (2012-2017)

4 MIDDLE EAST RECOMBINANT ANTIBODY (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Recombinant Antibody Sales and Value (2012-2017)
  4.1.1 Middle East Recombinant Antibody Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Recombinant Antibody Revenue and Growth Rate (2012-2017)
4.2 Middle East Recombinant Antibody Sales and Market Share by Type
4.3 Middle East Recombinant Antibody Sales and Market Share by Application
4.4 Middle East Recombinant Antibody Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Recombinant Antibody Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Recombinant Antibody Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Recombinant Antibody Sales and Growth Rate (2012-2017)
  4.4.4 Israel Recombinant Antibody Sales and Growth Rate (2012-2017)
  4.4.5 UAE Recombinant Antibody Sales and Growth Rate (2012-2017)
  4.4.6 Iran Recombinant Antibody Sales and Growth Rate (2012-2017)

5 AFRICA RECOMBINANT ANTIBODY (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Recombinant Antibody Sales and Value (2012-2017)
  5.1.1 Africa Recombinant Antibody Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Recombinant Antibody Revenue and Growth Rate (2012-2017)
5.2 Africa Recombinant Antibody Sales and Market Share by Type
5.3 Africa Recombinant Antibody Sales and Market Share by Application
5.4 Africa Recombinant Antibody Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Recombinant Antibody Sales Volume by Countries (2012-2017)
  5.4.2 Africa Recombinant Antibody Revenue by Countries (2012-2017)
  5.4.3 South Africa Recombinant Antibody Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Recombinant Antibody Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Recombinant Antibody Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Recombinant Antibody Sales and Growth Rate (2012-2017)

6 EMEA RECOMBINANT ANTIBODY MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Abnova
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Recombinant Antibody Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Abnova Recombinant Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Medix Biochemica
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Recombinant Antibody Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Medix Biochemica Recombinant Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 GE Healthcare
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Recombinant Antibody Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 GE Healthcare Recombinant Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 SinoBiological
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Recombinant Antibody Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 SinoBiological Recombinant Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Bioventix
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Recombinant Antibody Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Bioventix Recombinant Antibody Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview

7 RECOMBINANT ANTIBODY MANUFACTURING COST ANALYSIS

7.1 Recombinant Antibody Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Recombinant Antibody

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Recombinant Antibody Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Recombinant Antibody Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA RECOMBINANT ANTIBODY MARKET FORECAST (2017-2022)

11.1 EMEA Recombinant Antibody Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Recombinant Antibody Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Recombinant Antibody Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Recombinant Antibody Price and Trend Forecast (2017-2022)
11.2 EMEA Recombinant Antibody Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Recombinant Antibody Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Recombinant Antibody Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Recombinant Antibody Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Recombinant Antibody Sales Forecast by Type (2017-2022)
11.7 EMEA Recombinant Antibody Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Recombinant Antibody
Figure EMEA Recombinant Antibody Sales Volume (K Pcs) by Type (2012-2022)
Figure EMEA Recombinant Antibody Sales Volume Market Share by Type (Product Category) in 2016
Figure Chimeric Antibody Product Picture
Figure Humanized Antibody Product Picture
Figure Full Human Antibody Product Picture
Figure Single Chain Antibody Product Picture
Figure Bispecific Antibody Product Picture
Figure EMEA Recombinant Antibody Sales Volume (K Pcs) by Application (2012-2022)
Figure EMEA Sales Market Share of Recombinant Antibody by Application in 2016
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Scientific Research Examples
Table Key Downstream Customer in Scientific Research
Figure Others Examples
Table Key Downstream Customer in Others
Figure EMEA Recombinant Antibody Market Size (Million USD) by Region (2012-2022)
Figure Europe Recombinant Antibody Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Recombinant Antibody Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Recombinant Antibody Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Recombinant Antibody Revenue (Million USD) Status and Forecast by Countries
Figure Africa Recombinant Antibody Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Recombinant Antibody Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Recombinant Antibody Sales Volume and Growth Rate (2012-2022)
Figure EMEA Recombinant Antibody Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Recombinant Antibody Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table EMEA Recombinant Antibody Sales Volume (K Pcs) of Major Players (2012-2017)
Table EMEA Recombinant Antibody Sales Share by Players (2012-2017)
Figure 2016 Recombinant Antibody Sales Share by Players
Figure 2017 Recombinant Antibody Sales Share by Players
Figure EMEA Recombinant Antibody Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Recombinant Antibody Revenue (Million USD) by Players (2012-2017)
Table EMEA Recombinant Antibody Revenue Share by Players (2012-2017)
Table 2016 EMEA Recombinant Antibody Revenue Share by Players
Table 2017 EMEA Recombinant Antibody Revenue Share by Players
Table EMEA Recombinant Antibody Sale Price (USD/Pcs) by Players (2012-2017)
Table EMEA Recombinant Antibody Sales (K Pcs) and Market Share by Type (2012-2017)
Table EMEA Recombinant Antibody Sales Share by Type (2012-2017)
Figure Sales Market Share of Recombinant Antibody by Type (2012-2017)
Figure EMEA Recombinant Antibody Sales Market Share by Type (2012-2017)
Table EMEA Recombinant Antibody Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Recombinant Antibody Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Recombinant Antibody by Type in 2016
Table EMEA Recombinant Antibody Sale Price (USD/Pcs) by Type (2012-2017)
Table EMEA Recombinant Antibody Sales (K Pcs) and Market Share by Application (2012-2017)
Table EMEA Recombinant Antibody Sales Share by Application (2012-2017)
Figure Sales Market Share of Recombinant Antibody by Application (2012-2017)
Figure EMEA Recombinant Antibody Sales Market Share by Application in 2016
Table EMEA Recombinant Antibody Sales (K Pcs) and Market Share by Region (2012-2017)
Table EMEA Recombinant Antibody Sales Share by Region (2012-2017)
Figure Sales Market Share of Recombinant Antibody by Region (2012-2017)
Figure EMEA Recombinant Antibody Sales Market Share in 2016
Table EMEA Recombinant Antibody Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Recombinant Antibody Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Recombinant Antibody by Region (2012-2017)
Figure EMEA Recombinant Antibody Revenue Market Share Regions in 2016
Table EMEA Recombinant Antibody Sales Price (USD/Pcs) by Region (2012-2017)
Figure Europe Recombinant Antibody Sales (K Pcs) and Growth Rate (2012-2017)
Figure Europe Recombinant Antibody Revenue and Growth Rate (2012-2017)
Table Europe Recombinant Antibody Sales (K Pcs) by Type (2012-2017)
Table Europe Recombinant Antibody Market Share by Type (2012-2017)
Figure Europe Recombinant Antibody Market Share by Type in 2016
Table Europe Recombinant Antibody Sales (K Pcs) by Application (2012-2017)
Table Europe Recombinant Antibody Market Share by Application (2012-2017)
Figure Europe Recombinant Antibody Market Share by Application in 2016
Table Europe Recombinant Antibody Sales (K Pcs) by Countries (2012-2017)
Table Europe Recombinant Antibody Sales Market Share by Countries (2012-2017)
Figure Europe Recombinant Antibody Sales Market Share by Countries (2012-2017)
Figure Europe Recombinant Antibody Sales Market Share by Countries in 2016
Table Europe Recombinant Antibody Revenue (Million USD) by Countries (2012-2017)
Table Europe Recombinant Antibody Revenue Market Share by Countries (2012-2017)
Figure Europe Recombinant Antibody Revenue Market Share by Countries (2012-2017)
Figure Europe Recombinant Antibody Revenue Market Share by Countries in 2016
Figure Germany Recombinant Antibody Sales (K Pcs) and Growth Rate (2012-2017)
Figure France Recombinant Antibody Sales (K Pcs) and Growth Rate (2012-2017)
Figure UK Recombinant Antibody Sales (K Pcs) and Growth Rate (2012-2017)
Figure Russia Recombinant Antibody Sales (K Pcs) and Growth Rate (2012-2017)
Figure Italy Recombinant Antibody Sales (K Pcs) and Growth Rate (2012-2017)
Figure Benelux Recombinant Antibody Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Recombinant Antibody Sales (K Pcs) and Growth Rate (2012-2017)
Figure Middle East Recombinant Antibody Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Recombinant Antibody Sales (K Pcs) by Type (2012-2017)
Table Middle East Recombinant Antibody Market Share by Type (2012-2017)
Figure Middle East Recombinant Antibody Market Share by Type (2012-2017)
Table Middle East Recombinant Antibody Sales (K Pcs) by Applications (2012-2017)
Table Middle East Recombinant Antibody Market Share by Applications (2012-2017)
Figure Middle East Recombinant Antibody Sales Market Share by Application in 2016
Table Middle East Recombinant Antibody Sales Volume (K Pcs) by Countries (2012-2017)
Table Middle East Recombinant Antibody Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Recombinant Antibody Sales Volume Market Share by Countries in 2016
Table Middle East Recombinant Antibody Revenue (Million USD) by Countries (2012-2017)
Table Middle East Recombinant Antibody Revenue Market Share by Countries (2012-2017)
Figure Middle East Recombinant Antibody Revenue Market Share by Countries (2012-2017)
Figure Middle East Recombinant Antibody Revenue Market Share by Countries in 2016
Figure Saudi Arabia Recombinant Antibody Sales (K Pcs) and Growth Rate (2012-2017)
Figure Israel Recombinant Antibody Sales (K Pcs) and Growth Rate (2012-2017)
Figure UAE Recombinant Antibody Sales (K Pcs) and Growth Rate (2012-2017)
Figure Iran Recombinant Antibody Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Recombinant Antibody Sales (K Pcs) and Growth Rate (2012-2017)
Figure Africa Recombinant Antibody Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Recombinant Antibody Sales (K Pcs) by Type (2012-2017)
Table Africa Recombinant Antibody Sales Market Share by Type (2012-2017)
Figure Africa Recombinant Antibody Sales Market Share by Type (2012-2017)
Figure Africa Recombinant Antibody Sales Market Share by Type in 2016
Table Africa Recombinant Antibody Sales (K Pcs) by Application (2012-2017)
Table Africa Recombinant Antibody Sales Market Share by Application (2012-2017)
Figure Africa Recombinant Antibody Sales Market Share by Application (2012-2017)
Table Africa Recombinant Antibody Sales Volume (K Pcs) by Countries (2012-2017)
Table Africa Recombinant Antibody Sales Market Share by Countries (2012-2017)
Figure Africa Recombinant Antibody Sales Market Share by Countries (2012-2017)
Figure Africa Recombinant Antibody Sales Market Share by Countries in 2016
Table Africa Recombinant Antibody Revenue (Million USD) by Countries (2012-2017)
Table Africa Recombinant Antibody Revenue Market Share by Countries (2012-2017)
Figure Africa Recombinant Antibody Revenue Market Share by Countries (2012-2017)
Figure Africa Recombinant Antibody Revenue Market Share by Countries in 2016
Figure South Africa Recombinant Antibody Sales (K Pcs) and Growth Rate (2012-2017)
Figure Nigeria Recombinant Antibody Sales (K Pcs) and Growth Rate (2012-2017)
Figure Egypt Recombinant Antibody Sales (K Pcs) and Growth Rate (2012-2017)
Figure Algeria Recombinant Antibody Sales (K Pcs) and Growth Rate (2012-2017)
Table Abnova Recombinant Antibody Basic Information List
Table Abnova Recombinant Antibody Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Abnova Recombinant Antibody Sales (K Pcs) and Growth Rate (2012-2017)
Figure Abnova Recombinant Antibody Sales Market Share in EMEA (2012-2017)
Figure Abnova Recombinant Antibody Revenue Market Share in EMEA (2012-2017)
Table Medix Biochemica Recombinant Antibody Basic Information List
Table Medix Biochemica Recombinant Antibody Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Medix Biochemica Recombinant Antibody Sales (K Pcs) and Growth Rate (2012-2017)
Figure Medix Biochemica Recombinant Antibody Sales Market Share in EMEA (2012-2017)
Figure Medix Biochemica Recombinant Antibody Revenue Market Share in EMEA (2012-2017)
Table GE Healthcare Recombinant Antibody Basic Information List
Table GE Healthcare Recombinant Antibody Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure GE Healthcare Recombinant Antibody Sales (K Pcs) and Growth Rate (2012-2017)
Figure GE Healthcare Recombinant Antibody Sales Market Share in EMEA (2012-2017)
Figure GE Healthcare Recombinant Antibody Revenue Market Share in EMEA (2012-2017)
Table SinoBiological Recombinant Antibody Basic Information List
Table SinoBiological Recombinant Antibody Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure SinoBiological Recombinant Antibody Sales (K Pcs) and Growth Rate (2012-2017)
Figure SinoBiological Recombinant Antibody Sales Market Share in EMEA (2012-2017)
Figure SinoBiological Recombinant Antibody Revenue Market Share in EMEA (2012-2017)
Table Bioventix Recombinant Antibody Basic Information List
Table Bioventix Recombinant Antibody Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Bioventix Recombinant Antibody Sales (K Pcs) and Growth Rate (2012-2017)
Figure Bioventix Recombinant Antibody Sales Market Share in EMEA (2012-2017)
Figure Bioventix Recombinant Antibody Revenue Market Share in EMEA (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Recombinant Antibody
Figure Manufacturing Process Analysis of Recombinant Antibody
Figure Recombinant Antibody Industrial Chain Analysis
Table Raw Materials Sources of Recombinant Antibody Major Manufacturers in 2016
Table Major Buyers of Recombinant Antibody
Table Distributors/Traders List
Figure EMEA Recombinant Antibody Sales (K Pcs) and Growth Rate Forecast (2017-2022)
Figure EMEA Recombinant Antibody Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Recombinant Antibody Price (USD/Pcs) and Trend Forecast (2017-2022)
Table EMEA Recombinant Antibody Sales (K Pcs) Forecast by Region (2017-2022)
Figure EMEA Recombinant Antibody Sales Market Share Forecast by Region (2017-2022)
Table EMEA Recombinant Antibody Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Recombinant Antibody Revenue Market Share Forecast by Region (2017-2022)
Table Europe Recombinant Antibody Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Europe Recombinant Antibody Sales Market Share Forecast by Countries (2017-2022)
Table Europe Recombinant Antibody Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Recombinant Antibody Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Recombinant Antibody Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Middle East Recombinant Antibody Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Recombinant Antibody Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Recombinant Antibody Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Recombinant Antibody Sales (K Pcs) Forecast by Countries (2017-2022)
Figure Africa Recombinant Antibody Sales Market Share Forecast by Countries (2017-2022)
Table Africa Recombinant Antibody Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Recombinant Antibody Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Recombinant Antibody Sales (K Pcs) Forecast by Type (2017-2022)
Figure EMEA Recombinant Antibody Sales Market Share Forecast by Type (2017-2022)
Table EMEA Recombinant Antibody Sales (K Pcs) Forecast by Application (2017-2022)
Figure EMEA Recombinant Antibody Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources